Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene silencing
Biotech
Epicrispr gene silencer enhances muscle in muscular dystrophy
No other drug candidate has increased muscle mass in a facioscapulohumeral muscular dystrophy clinical trial, according to the company.
Darren Incorvaia
Jun 26, 2026 10:40am
Arrowhead takes aim at obesity with early gene silencing data
Jan 6, 2026 10:19am
Alnylam, Biogen build noise in Alzheimer's with gene silencing
Oct 26, 2023 8:51am
Lilly doubles down on ProQR's RNA tech in $75M deal expansion
Dec 22, 2022 10:38am
Alnylam, Regeneron hit go on genetic NASH therapy phase 2
Sep 15, 2022 8:09am
Chinese powerhouse continues charge into siRNA with Silence pact
Oct 15, 2021 7:15am
